Literature DB >> 31401189

Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process.

Mostafa Karimi Roshan1, Arash Soltani1, Anvar Soleimani2, Kolsoum Rezaie Kahkhaie3, Amir R Afshari4, Mohammad Soukhtanloo5.   

Abstract

Epithelial-mesenchymal transition (EMT) is a critical process in the development of many tissues and organs in multicellular organisms that its important role in the pathogenesis of metastasis and tumor cell migration has been firmly established. Decreased adhesive capacity, cytoskeletal reorganization, and increased mobility are hallmarks of the EMT. Several molecular mechanisms promote EMT, Including regulation of the levels of specific cell-surface proteins, ECM-degrading enzymes, and altering the expression of certain transcription factors and microRNAs. EMT process is modulated through multiple signaling pathways including the AKT/mTOR pathway. AKT is a key component in numerous processes which was recently shown to regulate the EMT through suppression of the expression of E-cadherin via EMT transcription factors. On the other hand, mTOR complexes can also regulate the EMT through the regulation of cell's actin cytoskeleton by altering the PKC phosphorylation state and direct phosphorylation and activation of Akt. Here we review the effect of AKT and mTOR on EMT and consequently metastasis and cell motility.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  AKT; E-cadherin; Epithelial-mesenchymal transition; Metastasis; mTOR

Mesh:

Substances:

Year:  2019        PMID: 31401189     DOI: 10.1016/j.biochi.2019.08.003

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  55 in total

Review 1.  RETRACTED ARTICLE: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours.

Authors:  Fei Xu; Lixin Na; Yanfei Li; Linjun Chen
Journal:  Cell Biosci       Date:  2020-04-01       Impact factor: 7.133

2.  AURKB Promotes the Metastasis of Gastric Cancer, Possibly by Inducing EMT.

Authors:  Zhen Wang; Zhu Yu; Gong-He Wang; Yi-Ming Zhou; Jian-Ping Deng; Yue Feng; Jun-Qiang Chen; Lei Tian
Journal:  Cancer Manag Res       Date:  2020-08-05       Impact factor: 3.989

3.  Chronic Leptin Treatment Induces Epithelial-Mesenchymal Transition in MCF10A Mammary Epithelial Cells.

Authors:  Juan Carlos Juárez-Cruz; Michal Okoniewski; Mónica Ramírez; Carlos Ortuño-Pineda; Napoleón Navarro-Tito; Eduardo Castañeda-Saucedo
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-02-23       Impact factor: 2.673

4.  UBE2L3 promotes lung adenocarcinoma invasion and metastasis through the GSK-3β/Snail signaling pathway.

Authors:  Xingjie Ma; Weibo Qi; Fan Yang; Huan Pan
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

5.  LMOD1, an oncogene associated with Lauren classification, regulates the metastasis of gastric cancer cells through the FAK-AKT/mTOR pathway.

Authors:  Yuen Tan; Qingchuan Chen; Siwei Pan; Wen An; Huimian Xu; Yao Xing; Jianjun Zhang
Journal:  BMC Cancer       Date:  2022-04-30       Impact factor: 4.638

6.  Elevated ZBTB7A expression in the tumor invasive front correlates with more tumor budding formation in gastric adenocarcinoma.

Authors:  Yujing Sun; Junyi He; Duan-Bo Shi; Hui Zhang; Xu Chen; Ai-Yan Xing; Peng Gao
Journal:  J Cancer Res Clin Oncol       Date:  2020-09-23       Impact factor: 4.553

7.  Y-box binding protein 1 (YB-1) promotes gefitinib resistance in lung adenocarcinoma cells by activating AKT signaling and epithelial-mesenchymal transition through targeting major vault protein (MVP).

Authors:  Lei Lou; Juan Wang; Fengzhu Lv; Guohui Wang; Yuehong Li; Lingxiao Xing; Haitao Shen; Xianghong Zhang
Journal:  Cell Oncol (Dordr)       Date:  2020-09-07       Impact factor: 6.730

8.  CCL21 activation of the MALAT1/SRSF1/mTOR axis underpins the development of gastric carcinoma.

Authors:  Qianmei Fu; Xiaohong Tan; Huaming Tang; Jijiang Liu
Journal:  J Transl Med       Date:  2021-05-17       Impact factor: 5.531

Review 9.  Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer.

Authors:  Zeinab Moafian; Abolfazl Maghrouni; Arash Soltani; Seyed Isaac Hashemy
Journal:  Mol Biol Rep       Date:  2021-05-31       Impact factor: 2.316

10.  B-Cell Receptor-Associated Protein 31 Promotes Metastasis via AKT/β-Catenin/Snail Pathway in Hepatocellular Carcinoma.

Authors:  Tengfei Liu; Junming Yu; Chao Ge; Fangyu Zhao; Chunxiao Miao; Wenjiao Jin; Yang Su; Qin Geng; Taoyang Chen; Haiyang Xie; Ying Cui; Ming Yao; Jinjun Li; Helei Hou; Hong Li
Journal:  Front Mol Biosci       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.